Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Luckin Coffee Announces First Quarter 2026 Financial Results and Share Repurchase Program
-
OTC Markets Group Welcomes K2 Gold Corp to OTCQX
-
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at th
-
Kandi Technologies Releases CEO Letter to Shareholders
-
EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026
-
Village Farms International to Report Q1 2026 Results on May 11, 2026
-
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
-
Aeluma to Announce Third Quarter Fiscal Year 2026 Financial Results on May 13, 2026
-
Form 8.3 - Picton Property Income Limited
-
Brookfield Infrastructure Reports Strong First Quarter 2026 Results
-
SNDL Reports First Quarter 2026 Financial and Operational Results
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives
-
Kite Realty Group Reports First Quarter 2026 Operating Results
-
Virtu Announces First Quarter 2026 Results
-
ScottsMiracle-Gro Reports Strong Second Quarter Results; Increase in Sales and Gross Margin Improvement Drive EPS Growth
-
Form 8.3 - LondonMetric Property Plc & Schroder REIT Limited
-
Form 8.3 - Bluefield Solar Income Fund Ltd.
-
The 9th Digital China Summit opens in Fuzhou, Fujian Province
-
Form 8.3 - Augmentum Fintech Plc
-
Navient posts first quarter 2026 financial results
-
Battalion Oil Increases Compression Capacity, Building on Previously Announced Midstream Reliability
-
Form 8.3 - Advanced Medical Solutions Group
-
Oma Savings Bank Plc to publish its January-March 2026 interim report and hold a webcast on 7 May 2026
-
Resolutions of Huhtamäki Oyj’s Annual General Meeting of Shareholders and the organizational meeting of the Board of Directors
-
Decisions of the Annual General Meeting 2026
-
Cliq Digital AG decides to conduct a public partial share repurchase offer for up to 51% of the Company's share capital
-
Yimutian Inc. Announces Plan to Implement Change in American Depositary Shares (ADS) to Ordinary Share Ratio
-
Regeneron Reports First Quarter 2026 Financial and Operating Results
-
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
-
Parsons Reports First Quarter 2026 Results
-
Quarterly Activities and Cashflow Report - March 2026
-
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
-
Costamare Inc. Reports Results For The First Quarter Ended March 31, 2026
-
Aviatrix Defines the Containment Era, Answers the Priority Question at the Center of AI-Accelerated Cyber Risk
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Aviatrix Operationalizes the Containment Era with the Industry's First Containment Platform for AI Agents
-
First Atlantic Nickel & Cobalt Welcomes Dr. Douglas Wicks, Former Program Director for the U.S. Department of Energy's ARPA-E (Advanced Research Projects Agency-Energy) Miner Program and Geologic Hydr
-
Man Group PLC : Form 8.3 - A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited
-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
Allot to Present at the 21st Annual Needham Technology, Media & Consumer Conference on May 13, 2026
-
Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI)-NCC Group plc
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
Form 8.5 (EPT/RI) - Kore Potash Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - NCC GROUP PLC - Ordinary Shares
-
Canadians would rather do just about anything than read their home insurance policy, Allstate Canada survey finds
-
Allot to Present at the 21st Annual Needham Technology, Media & Consumer Conference on May 13, 2026
-
HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
